Boston Scientific Corporation (NYSE:BSX) will release earnings for its first quarter before the opening bell on Wednesday, April 22.
Analysts expect the Marlborough, Massachusetts-based company to report quarterly earnings of 79 cents per share. That’s up from 75 cents per share in the year-ago period. The consensus estimate for Boston Scientific’s quarterly revenue is $5.17 billion (it reported $4.66 billion last year), according to Benzinga Pro.
On March 28, Boston Scientific announced data from its HI-PEITHO clinical trial evaluating the EKOS Endovascular System in patients with pulmonary embolism.
Shares of Boston Scientific fell 2.4% to close at $59.52 on Tuesday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
This post was originally published here
